Nitrosamines are potential contaminants of drug products. Contamination can occur from synthesizing APIs and excipients, from leaching into the product from primary packaging, and more.
Unearth what immune checkpoint inhibitors are showing promise in treating cervical cancer and how advancements in these treatments paired with additional strategies are improving patient outcomes.
This e-book provides insight into some of the issues and trends shaping drug delivery and explores solutions promoting the efficiency, reliability, and safety of the pharmaceutical drug supply.
